In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Compugen Ltd.

Latest From Compugen Ltd.

Israel Looks To Nurture New Leaders For Burgeoning Biotech Sector

While Israel has not wanted for early-stage scientific excellence, leading lights in the country's biotech space are working to create an ecosystem where clinical, regulatory and managerial expertise can develop.

Growth Business Strategies

Immuno-Oncology: Unicorns, China And The Perfect Storm

There is a unique phenomenon being realized in immuno-oncology deal-making compared with other segments in the life sciences sector – an apparent uncoupling between risk and return on invested capital, as early assets provide similar liquidity to more mature assets.

ImmunoOncology Market Intelligence

Deal Watch, Licensing & Alliances: Amgen Places $66m Bet On Genetic Sequencing

Already partnered with Oxford Nanopore through its acquisition of deCODE Genetics, Amgen invests in the UK biotech to enhance its genomic capabilities. Aclaris licenses dermatology product Rhofade from Allergan. Other recent licensing and alliance deals... 

Deals Business Strategies

Spotlight On Israel: Compugen Comes Forth

Compugen, a predictive drug discovery and development company, plays an important role within Israel's biopharma sector as one of the oldest businesses in an immature market. Building on its 25-year history, the company is about to embark on a new challenge: clinical development.

Israel Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Compugen Ltd.
  • Senior Management
  • Anat Cohen-Dayag, PhD, Pres. & CEO
    Ari Krashin, CFO & COO
    Oliver Froescheis, PhD, SVP, Corp. & Bus. Dev.
    Henry Adewoye, MD, CMO
    John Hunter, PhD, CSO
  • Contact Info
  • Compugen Ltd.
    Phone: (972) 3 765 8585
    26 Harokmim St. Bldg D
    Azrieli Ctr.
    Holon, 5885849